BIO Applauds the Inclusion of Important Health Care and Agriculture Priorities and Programs in Year-end Government Funding Bill

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many urgent and bipartisan health care and agricultural priorities and programs:Continue reading

The Corporate Transparency Act – Is it on Life Support?

In Texas Top Cop Shop, Inc. et al. v. Merrick Garland, a U.S. District Court in Texas has issued a potentially major setback to the continued application of the Corporate Transparency Act (CTA), which became effective on January 1, 2024. The CTA was passed in 2021 to help gather information to assist in the support of anti-money laundering and anti-terrorism investigations and enforcement of related laws. However, the CTA required onerous reporting requirements for companies, while providing exceptions for large entities. The anticipated impact of the CTA on investment entities, small businesses, and other complex structures related to corporate governance was considered significant.Continue reading